TABLE 3.
Variable | Cmax,ss, ng/ml | AUCss, ng h/ml | ||||||
---|---|---|---|---|---|---|---|---|
Healthy control |
Mild HI |
Moderate HI |
Severe HI |
Healthy control |
Mild HI |
Moderate HI |
Severe HI |
|
Olanzapine | 34.4 | 40.9 | 51.2 | 53.2 | 688 | 783 | 1031 | 1077 |
Ratioa | — | 1.19 | 1.49 | 1.55 | — | 1.14 | 1.50 | 1.57 |
Samidorphan | 35.2 | 51.8 | 63.0 | 74.0 | 261 | 321 | 495 | 604 |
Ratioa | — | 1.47 | 1.79 | 2.10 | — | 1.23 | 1.90 | 2.32 |
Abbreviations: AUCss, area under the plasma drug concentration‐time curve at steady state; Cmax,ss maximum plasma concentration at steady state; HI, hepatic impairment; OLZ/SAM, combination of olanzapine and samidorphan.
Relative to age‐matched controls with normal hepatic function.